PulmoStem (AmnioPul-02)
/ Amniotics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 10, 2023
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI
(clinicaltrials.gov)
- P1b | N=6 | Completed | Sponsor: Amniotics AB | Not yet recruiting ➔ Completed | N=18 ➔ 6 | Trial completion date: Jun 2024 ➔ Feb 2023 | Initiation date: Jun 2022 ➔ Oct 2022 | Trial primary completion date: Jun 2023 ➔ Feb 2023
Enrollment change • Trial completion • Trial completion date • Trial initiation date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 27, 2022
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19
(clinicaltrials.gov)
- P1b | N=18 | Not yet recruiting | Sponsor: Amniotics AB
New P1 trial • Infectious Disease • Novel Coronavirus Disease
1 to 2
Of
2
Go to page
1